Cargando…
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
BACKGROUND: Colonoscopy is currently widely accepted as the gold standard for detection of colorectal cancer (CRC) providing detection of up to 95% of pre-cancerous lesions during the procedure. However, certain limitations exist in most countries including cost and access to the procedure. Moreover...
Autores principales: | Rahier, Jean-François, Druez, Anne, Faugeras, Laurence, Martinet, Jean-Paul, Géhénot, Myriam, Josseaux, Eléonore, Herzog, Marielle, Micallef, Jake, George, Fabienne, Delos, Monique, De Ronde, Thierry, Badaoui, Abdenor, D’Hondt, Lionel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433015/ https://www.ncbi.nlm.nih.gov/pubmed/28515797 http://dx.doi.org/10.1186/s13148-017-0351-5 |
Ejemplares similares
-
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017) -
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015) -
JAK inhibitor, a new player for treatment-refractory microscopic colitis
por: Druez, Anne, et al.
Publicado: (2023) -
The histone demethylase Kdm3a is essential to progression through differentiation
por: Herzog, Marielle, et al.
Publicado: (2012) -
Intramedullary spinal cord metastasis of cholangiocarcinoma: a case report
por: Faugeras, Laurence, et al.
Publicado: (2015)